127 related articles for article (PubMed ID: 2438847)
21. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
[No Abstract] [Full Text] [Related]
22. Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms.
Goldenberg DM; Kim EE; Bennett SJ; Nelson MO; Deland FH
Gastroenterology; 1983 Mar; 84(3):524-32. PubMed ID: 6295871
[TBL] [Abstract][Full Text] [Related]
23. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
Terabe K; Ichihashi H; Kamei H; Kondo T
Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
[TBL] [Abstract][Full Text] [Related]
25. Oncofetal antigens. Increasing the specificity of the CEA radioimmunoassay.
Shuster J; Freedman SO; Gold P
Am J Clin Pathol; 1977 Nov; 68(5 Suppl):679-87. PubMed ID: 72501
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobin levels in patients with Hodgkin's disease.
Dienstbier Z; Koprivová H; Bechynĕ M; Zizkovský V; Foltýnová V; Rezný Z; Jirkovský J
Neoplasma; 1978; 25(6):723-31. PubMed ID: 752117
[TBL] [Abstract][Full Text] [Related]
27. [Plasma levels of alpha-fetoprotein and carcinoembryonic antigen in patients with malignant gastrointestinal tumors].
Monteiro JC; Moreira MM; Pereira FE; de Oliveira LR; da Cunha EA; Leite JF; Castro e Sousa F
Acta Med Port; 1989; 2(6):245-52. PubMed ID: 2483025
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulins intrinsic to colorectal carcinoma: an unfavorable prognostic association with IgM.
Jones SL; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR; Rollo AJ
J Natl Cancer Inst; 1983 Sep; 71(3):469-72. PubMed ID: 6577222
[TBL] [Abstract][Full Text] [Related]
29. Significance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy.
Lamerz R; Ruider H
Bull Cancer; 1976; 63(4):575-86. PubMed ID: 1021185
[No Abstract] [Full Text] [Related]
30. Serum CEA levels in gastrointestinal diseases.
Miwa M; Senoue I; Watanabe H; Nomiyama T; Suzuki S; Harasawa S; Tani N; Miwa T; Mitomi T; Hata J
Tokai J Exp Clin Med; 1980 Apr; 5(2):151-3. PubMed ID: 7414628
[TBL] [Abstract][Full Text] [Related]
31. The use of carcinoembryonic antigen in the clinical management of patients with colorectal cancer.
Steele G; Zamcheck N
Cancer Detect Prev; 1985; 8(3):421-7. PubMed ID: 4064062
[TBL] [Abstract][Full Text] [Related]
32. Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer.
Dixon MR; Haukoos JS; Udani SM; Naghi JJ; Arnell TD; Kumar RR; Stamos MJ
Arch Surg; 2003 Sep; 138(9):962-6. PubMed ID: 12963652
[TBL] [Abstract][Full Text] [Related]
33. Proceedings: Comparison between collagenase activity in rectal biopsies and plasma carcinoembryonic antigen (CEA) levels in patients with carcinoma of the colon and rectum.
Lesher T; Dilwari JB; Hawley PR
Gut; 1973 Oct; 14(10):819. PubMed ID: 4357151
[No Abstract] [Full Text] [Related]
34. [Tumor markers in colorectal neoplasm pathology: our experience of the diagnostic and prognostic importance of CEA antigen].
Tessera G; Dall'Acqua S; De Bernardi A; Crivelli F; Gallioli G
Chir Ital; 1988 Dec; 40(6):377-87. PubMed ID: 3267476
[TBL] [Abstract][Full Text] [Related]
35. [Key role of the CEA test in the diagnosis and surgical therapy of recurrent colorectal cancer].
Quentmeier A; Schlag P; Herfarth C
Chirurg; 1986 Feb; 57(2):83-7. PubMed ID: 3698741
[TBL] [Abstract][Full Text] [Related]
36. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
[TBL] [Abstract][Full Text] [Related]
37. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
38. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
Ławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
[TBL] [Abstract][Full Text] [Related]
39. The role of tumor markers in the management of colorectal cancer.
Go VL; Zamcheck N
Cancer; 1982 Dec; 50(11 Suppl):2618-23. PubMed ID: 7139557
[TBL] [Abstract][Full Text] [Related]
40. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
